Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Citoquinas proinflamatorias como marcador diagnóstico en el síndrome vestibular episódico

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOES20190404006
Publicado:
02/05/2019
Caducidad:
02/05/2020
Resumen:
Un grupo de investigación español del Sistema Nacional de Salud ha desarrollado una tecnología de diagnóstico en el síndrome vestibular episódico (SVE) mediante el uso de citoquinas proinflamatorias. El SVE es un estado clínico caracterizado por mareos o vértigo recurrentes que se desarrolla de forma intensa en segundos, minutos u horas y que se acompaña de náuseas, inestabilidad para caminar, nistagmo o intolerancia al movimiento de la cabeza. El estado desaparece clínicamente en 24 horas y no está relacionado con el movimiento de la cabeza, posición/postura de la cabeza ni posición/postura del cuerpo. Los marcadores biológicos para el diagnóstico del SVE difieren del método tradicional basado en ensayos clínicos. El diagnóstico diferencial entre la migraña vestibular y la enfermedad de Ménière en fase preliminar permite el uso de las terapias apropiadas y evita el tratamiento agresivo en pacientes con diagnósticos equivocados. El grupo de investigación busca socios con el fin de establecer acuerdos de licencia o cooperación pública o privada para continuar con el desarrollo de la tecnología patentada.

Details

Tittle:
Proinflammatory cytokines as a diagnostic marker in the episodic vestibular syndrome
Summary:
A Spanish research group of the public health system has developed a diagnostic technology in the episodic vestibular syndrome (EVS) by using proinflammatory cytokines. A license agreement or an agreement for a public or private partnership for the further development of the patented technology is sought.
Description:
The episodic vestibular syndrome (EVS) is a clinical condition characterized by recurrent dizziness or vertigo that develops acutely (over seconds, minutes, or hours), may be accompanied by nausea, gait instability, nystagmus, or head-motion intolerance. It disappears clinically within 24 hours and is not linked to head motion, head position/posture or body position/posture.

The classification of the episodic vestibular syndrome (EVS) has always been based on clinical symptoms, and no biological markers have been used for its diagnosis.

The Spanish research group has developed a method of diagnostic using proinflammatory cytokines in the episodic vestibular syndrome. The method is orientated to the patient classification that have Episodic Vestibular Syndrome with migraine and/or with hearing-impaired, with specific approaches for the differential diagnostic of Vestibular Migraine (VM) and Meniere´s disease (MD).

Vestibular Migraine (VM) or migrainous vertigo is a type of migraine that may or may not cause a headache, but can include a number of debilitating symptoms affecting the ears, vision and balance.
Meniere´s disease (MD) is a disorder of the inner ear that can lead to dizzy spells (vertigo) and hearing loss.

The group is looking for the following collaboration:
-License agreement, in the framework of authorizing the interested parties to use the technology.
-Technical cooperation agreement, to collaborate with other research teams, companies or foundations to improve the technologies.
Advantages and Innovations:
- Biological markers for the diagnostic of Episodic Vestibular Syndrome that differ from the traditional method based on clinical trials.

- Differential diagnostic between VM and EM in preliminary stage, allow the pertinent use of therapies, avoiding aggressive treatment in misdiagnosis patients.
Stage of Development:
Available for demonstration
IPs:
Patent(s) applied for but not yet granted
CommeR Statunts Regarding IPR Status:
PCT application

Partner sought

Type and Role of Partner Sought:
The research group aims to formalize a technology transfer process with entities interested in the implementation of the solution, through a license agreement.

If there are some entities, such as R-Y-D centres, technology centres or specialized companies, interested in collaborating and developing further aspects of the solution, a technical cooperation agreement could be envisaged.

Client

Type and Size of Client:
R&D Institution
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English
Spanish

Keywords

Technology Keywords:
06001005 Diagnósticos, diagnosis
06001014 Neurología, investigación cerebral